Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.
about
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentIrisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK.Increased FNDC5 is associated with insulin resistance in high fat-fed mice.Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular riskFNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs.Effects of elastic band resistance training and nutritional supplementation on muscle quality and circulating muscle growth and degradation factors of institutionalized elderly women: the Vienna Active Ageing Study (VAAS)Locus characterization and gene expression of bovine FNDC5: is the myokine irisin relevant in cattle?Serum Irisin Level Can Predict the Severity of Coronary Artery Disease in Patients with Stable Angina.Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice.Crosstalk between adipokines and myokines in fat browning.Activin A and follistatin in patients with nonalcoholic fatty liver disease.Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events.Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines.Irisin ERKs the fat.Association of serum irisin concentrations with the presence and severity of obstructive sleep apnea syndrome.Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.Metabolism: Irisin, the metabolic syndrome and follistatin in humans.
P2860
Q26775254-9F013637-ABB9-4174-98A4-F9CFB7E6358CQ33631704-37472EEE-FC23-44FB-9623-FA3A6DC77CA4Q33896069-5C13B69C-1922-431B-BD50-B0C5838C8F43Q34244014-263F6C78-598B-426A-B728-CD551582C320Q34577335-2B1D6A74-0E15-4286-A018-EAAE5461B557Q36805120-6FB0F664-FD33-40E6-8E9E-21E785EC2B41Q37539477-F55071CD-053A-4A5E-9F98-585BEEB8294FQ37619078-BA48D5D9-4363-49ED-8D8C-F6C9EABFD1B1Q38304356-4D6370D7-2C50-4236-BFBA-1F8C8EA47E6CQ38797210-451BBEF4-3E50-47F5-98FC-433A171E5179Q38821923-18307E52-DD52-44BD-BE5F-1F1D1C92E880Q39177568-9B21338D-0740-4DAD-9CDC-A83A1C693112Q40771447-7E66A7F5-75F0-4B7C-9BE6-F483CD0366A2Q41944288-9905269B-184B-4BFA-BA1A-1A471C707E61Q47808282-13D790D2-F085-4006-BCDF-FC644625408AQ52606244-D6B7FDAC-2D10-4038-829E-A19835E4CC73Q54577936-3F2FFC81-0484-4D6A-86A1-D4ECB6BF5F25
P2860
Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@en
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@nl
type
label
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@en
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@nl
prefLabel
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@en
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@nl
P2093
P2860
P50
P356
P1476
Irisin mRNA and circulating le ...... thy and morbidly obese humans.
@en
P2093
Christos S Mantzoros
Costas A Christophi
David C Christiani
Joo Young Huh
Maria T Vamvini
Mary T Brinkoetter
Michael Petrou
Stefanos N Kales
P2860
P304
P356
10.1530/EJE-13-0276
P577
2013-10-21T00:00:00Z